Today in News History
On July 12, several notable moments in the history of News stand out. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1925, Roger Smith, American businessman (died 2007) was born. In 1947, Richard C. McCarty, American psychologist and academic was born. In 1949, Rick Hendrick, American businessman, founded Hendrick Motorsports was born. In 1952, Voja Antonić, Serbian computer scientist and journalist, designed the Galaksija computer was born. In 1973, Christian Vieri, Italian footballer was born. In 1974, Stelios Giannakopoulos, Greek footballer and manager was born. In 1980, Kristen Connolly, American actress was born. In 1982, Antonio Cassano, Italian footballer was born. In 1990, Rachel Brosnahan, American actress was born. Together, these milestones provide historical context for today's news news and ongoing narratives.
Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy?
Immuno-oncology specialist Corvus Pharmaceuticals reported a recent insider buy amid a year of sharp share price gains.
Narrative Intelligence Brief
This article was published by The Motley Fool, a source frequently categorized with a lean left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Motley Fool, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from The Motley Fool
July 12, 2026
Why Interactive Brokers Stock Zoomed 35.3% Higher In The First Half of 2026
July 12, 2026
Nvidia's Forward P/E Has Actually Fallen as Its Stock Price Rose. Here's How That's Possible.
July 12, 2026
AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty
July 11, 2026
Warren Buffett Swears By This 1 Low-Cost Investment. History Proves He's Been Right Every Time.
July 11, 2026
The Vanguard ETF Warren Buffett Endorsed in 2014 Would Have Turned $5,000 Into $20,465 Today
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinals"
Jude Bellingham's star shines as risk-averse England advance to World Cup semifinals over tepid Norway
Bellingham carries England past Norway and into World Cup semifinals
England defeat Norway 2-1 as Jude Bellingham shines in World Cup quarterfinal
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 33%
Center 33%
Right 33%
Bloomberg
· Jul 7, 2026
SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers
On this episode of Stock Movers: - Fiserv (FISV) is climbing as the Wall Street Journal reports big banks including JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group have held preliminary discussions about a deal to acquire a network owned by the financial-technology company Fiserv. - Crinetics Pharmaceuticals (CRNC) is soaring after Vertex Pharmaceuticals agreed to buy Crinetics for 10 billion in cash to expand into endocrinology. - SpaceX (SPCX) is lower even though at least six brokers, including Morgan Stanley and Goldman Sachs, have started coverage of SpaceX with buy-equivalent ratings. SpaceX’s addition to the Nasdaq 100 should provide considerable support to the stock, considering the number of funds that track the tech-heavy benchmark. (Source: Bloomberg)
Seeking Alpha
· Jul 9, 2026
Caesars Entertainment: Why A Merger Arb Trade Could Be Worth A Flyer
Caesars Entertainment: Why A Merger Arb Trade Could Be Worth A Flyer
The Hindu BusinessLine
· Jul 1, 2026
Renfra Energy submits papers with SEBI for IPO; eyes ₹430-cr via fresh issue
Along with the fresh issue, there will be an Offer-for-Sale (OFS) of 47,94,800 equity shares by the selling shareholders
BusinessWorld Online
· Jul 8, 2026
SEC OKs San Miguel’s P30-B preferred share offering
THE Securities and Exchange Commission (SEC) has approved the registration of San Miguel Corp.’s (SMC) follow-on offering of preferred shares worth up to P30 billion. In a July 7 meeting, the SEC Commission En Banc declared effective SMC’s registration statement covering 400 million Series 2 preferred shares, subject to the company’s compliance with remaining regulatory []
The Motley Fool
· Jun 22, 2026
2 Nuclear Stocks Worth Buying After the SpaceX IPO
SpaceX is shedding light on how important energy is for AI.
Inc.com
· Jul 8, 2026
Why So Many Founders Regret Selling—Even After a Big Payday
Research by the Exit Planning Institute has found that roughly three-quarters of owners regret selling within a year of closing. But why?
Topics:
Related coverage for "Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy?": Bloomberg — SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers. Seeking Alpha — Caesars Entertainment: Why A Merger Arb Trade Could Be Worth A Flyer. The Hindu BusinessLine — Renfra Energy submits papers with SEBI for IPO; eyes ₹430-cr via fresh issue. BusinessWorld Online — SEC OKs San Miguel’s P30-B preferred share offering. The Motley Fool — 2 Nuclear Stocks Worth Buying After the SpaceX IPO. Inc.com — Why So Many Founders Regret Selling—Even After a Big Payday